HLA-A*02:01 PRAME 142-151 Tetramer-SLYSFPEPEA-PE
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
Target | Cancer |
---|---|
Product Type | Tetramer |
Application | FCM |
Conjugate | PE |
Class | Class I |
Species Reactivity | Human |
Allele | HLA-A*02:01 |
Peptide Sequence | SLYSFPEPEA |
Research Area | Immunology, Immune Monitoring |
Protocols | FCM |
Specificity | PRAME |
Storage Temperature | 4°C |
Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
Related Products
Related Content
SCIENTIFIC POSTER